Breaking News
May 25, 2018 - Melorheostosis – Genetics Home Reference
May 25, 2018 - Non-addictive pain medication changing therapy for substance use disorders
May 25, 2018 - Delayed lactate measurements in sepsis patients increase risk of in-hospital death
May 25, 2018 - Researchers identify novel epigenetic mutations as cause of neurodevelopmental, congenital disorders
May 25, 2018 - UD researchers examine connection between DNA replication in HPV and cancer
May 25, 2018 - Researchers identify neurons that play key role in aggressive behavior
May 25, 2018 - Researchers discover unexpected chemosensor pathway for predator odor-evoked innate fear behaviors
May 25, 2018 - Nearly one in three people know someone addicted to opioids
May 25, 2018 - New findings could help fine-tune treatment for cancer patients
May 25, 2018 - New cancer treatment approach targets specific sugar receptors
May 25, 2018 - Skin responsible for uptake of cancer-causing compounds during barbecuing than lungs
May 25, 2018 - Early-onset cannabis use linked to further drug abuse problems
May 25, 2018 - Covered California takes aim at hospital C-section rates
May 25, 2018 - FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria
May 25, 2018 - Arthritis Glossary
May 25, 2018 - Study links breast cancer to the body’s internal clock
May 25, 2018 - Strenuous exercise in teenage years may protect against height loss later in life
May 25, 2018 - FDA approves novel enzyme therapy for adults with rare and serious genetic disease
May 25, 2018 - New research project aims at developing effective interventions for kids with DLD
May 25, 2018 - Middlemen who save $$ on medicines — but maybe not for you
May 25, 2018 - Study sheds new light on sharp rise in fatal drug overdoses in recent years
May 25, 2018 - Students propose revision of listeriosis guidelines for safer pregnancy
May 25, 2018 - TNFi Exposure In Utero Does Not Up Serious Infection Risk
May 25, 2018 - Organization of cells in the inner ear enables the sense and sensitivity of hearing
May 25, 2018 - Yoga May Be Right Move Against Urinary Incontinence
May 25, 2018 - Drinking recommended amount of milk could protect obese children against metabolic syndrome
May 25, 2018 - New cytokine network can repair tissue damage in the intestine, study finds
May 25, 2018 - Lyme disease researcher dispels misconceptions about ticks and provides prevention tips
May 25, 2018 - Penn researchers find link between social media usage and underage drinking
May 25, 2018 - Unique nanotechnology method to simplify skin disease diagnosis
May 25, 2018 - Study reveals new protective mechanism for tumor cells in breast cancer
May 25, 2018 - FRAME Alternatives Laboratory chosen for major European liver research collaboration
May 25, 2018 - Study shows yogurt may dampen chronic inflammation linked to multiple diseases
May 25, 2018 - Invasive cancers that are born to be bad show detectable differences from harmless tumors
May 25, 2018 - Study identifies new mechanism involved in development of Lou Gehrig’s disease
May 25, 2018 - UAB professor receives award for malaria prevention study in pregnant women in Cameroon
May 25, 2018 - Study provides blueprint of how fruit flies can be used to screen potentially pathogenic human genes
May 25, 2018 - New drug-delivering nanoparticle could offer better way to treat brain tumors
May 25, 2018 - Kessler Foundation scientists compare two tests for assessing learning in individuals with MS
May 25, 2018 - Stroke Symptoms and Diagnosis (Beyond the Basics)
May 25, 2018 - Protein goes against the family to prevent cancer
May 25, 2018 - Drugmakers blamed for blocking generics have milked prices and cost U.S. billions
May 25, 2018 - Speakers announced for National Medicines Symposium 2018
May 25, 2018 - GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
May 25, 2018 - Pfizer settles kickback case related to copay assistance for $24m
May 25, 2018 - Nuclear pore functions are essential for T cell survival
May 25, 2018 - Study defines molecular basis to explain connection between mother’s nutrition and infant growth
May 24, 2018 - IHI hosts representatives to develop a national action plan for patient safety
May 24, 2018 - Zika detection breakthrough by University of Queensland
May 24, 2018 - FDA Alert: 95% Ethyl Alcohol Product by Ethanol Extraction: Recall
May 24, 2018 - New method allows scientists to study how HIV persists
May 24, 2018 - Study reveals rate of vertebral and non-vertebral fractures in children with leukemia
May 24, 2018 - Whey protein supplementation and physical activity aid women in improving body composition
May 24, 2018 - Seniors’ air pollution exposure linked to hospitalization for ARDS
May 24, 2018 - Home-based telehealth therapy program effective for stroke rehabilitation, shows study
May 24, 2018 - Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates
May 24, 2018 - Opioid addiction treatment drug helps suppress HIV in former prisoners
May 24, 2018 - FDA warns against using teething remedies for babies
May 24, 2018 - Healthy lifestyle counseling program linked to reduced risk of developing cancers
May 24, 2018 - CU research sheds light on liver disease caused by intravenous nutrition
May 24, 2018 - Skin cream containing rapamycin reduces TSC-related facial tumors
May 24, 2018 - Suicide rates twice as high among black children finds new study
May 24, 2018 - Researchers find new method to treat severe asthma
May 24, 2018 - Scientists report new strategy for fighting bacteria
May 24, 2018 - South Asians living in the United States more likely to die of heart disease and stroke
May 24, 2018 - Health Tip: Why Get a Biopsy
May 24, 2018 - Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012
May 24, 2018 - Motivation to move may start with being mindful
May 24, 2018 - Advanced genetics study of TB bacteria uncovers virulent ‘Beijing lineage’ strain among young adults
May 24, 2018 - Friends tend to have similar pain tolerance levels, study reveals
May 24, 2018 - International researchers succeed in stopping growth of mesothelioma in model animals
May 24, 2018 - Inactive people find high-intensity interval training to be as enjoyable as traditional exercise
May 24, 2018 - Now more of us can count on more time dodging the dementia bullet
May 24, 2018 - Scientists develop new test to predict woman’s risk of preterm birth
May 24, 2018 - Global healthcare access and quality improved from 2000-2016
May 24, 2018 - Virtual follow-up visits for hypertension care just as effective as in-person office visits
May 24, 2018 - New research reveals links between type 1 diabetes and mental health
May 24, 2018 - Antioxidant-enriched multivitamin may decrease respiratory illnesses in CF patients, finds study
May 24, 2018 - Antidepressant treatments increase risk of weight gain, study finds
May 24, 2018 - INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray
Cell-Free DNA May Help Pinpoint Breast Ca Survival

Cell-Free DNA May Help Pinpoint Breast Ca Survival

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that a high tumor fraction of cell-free DNA is prognostic of worse survival in patients with metastatic triple-negative breast cancer.
  • Be aware that this disease carries a poor prognosis overall, making further risk stratification an important step towards targeting potentially toxic therapies.

The tumor fraction of cell-free DNA (cfDNA) sample can be used to predict survival in patients with metastatic triple-negative breast cancer (TNBC), investigators reported.

This suggests that determining cfDNA tumor fraction via a minimally invasive blood test can provide “important prognostic information beyond standard clinicopathologic factors,” according to Daniel G. Stover, MD, of the Ohio State University Comprehensive Cancer Center in Columbus, and colleagues.

A diagnosis of TNBC means that the breast cancer cells have tested negative for hormone epidermal growth factor receptor 2 (HER-2), and estrogen and progesterone receptors. TNBC accounts for 10% to 15% of breast cancers, yet is responsible for more than one-third of breast cancer deaths, the authors wrote in the Journal of Clinical Oncology.

They also noted that TNBC is characterized by relatively few mutations, but widespread somatic copy number alterations (SCNAs), suggesting SCNAs play a critical from in the formation of TNBC tumors. Stover’s group evaluated SCNAs in metastatic TNBC via cfDNA to determine whether cfDNA tumor fraction was associated with overall metastatic TNBC survival.

For this retrospective cohort study, they identified 506 plasma samples from 164 patients with biopsy-proven metastatic TNBC. All patients received chemotherapy before blood collection, with most patients receiving neoadjuvant or adjuvant anthracycline and taxane-based chemotherapy.

The researchers used an algorithm, ichorCNA, to profile SCNAs and quantify tumor fraction (TFx) in cfDNA from low-coverage whole-genome sequencing without prior knowledge of the genomic changes in the patient’s tumor.

Stover’s group was able to determine tumor fraction of cfDNA for 158 patients (96.3%). Also, 101 of those 158 patients (63.9%) had at least one sample with TFx equal to or greater than the prespecified cfDNA tumor fraction threshold of 10%.

Crucially, they found that patients with the higher tumor fraction of ≥10% was associated with a “significantly shorter survival” — median 6.4 months versus 15.9 months — and that this association remained significant independent of clinicopathologic factors (hazard ratio 2.14, 95% CI 1.4-3.8).

The analysis also identified several genes — NOTCH2, AKT2, and AKT3 — that had copy number gains enriched in metastatic TNBCs relative to primary TNBCs. In an accompanying commentary, Sarah-Jane Dawson, MD, PhD, of the Peter MacCallum Cancer Center in Melbourne, Australia, and colleague observed that this “sheds light on important genes and signaling pathways that may be perturbed in metastatic disease.”

Stover’s group also found that more than half of metastatic TNBCs harbored gains or amplification of 18q11, 19p13, or both, which was significantly more frequent than in primary TNBCs. “Gain or amplification of both regions identifies a subset of TNBC rapid progressors with remarkably poor survival in the metastatic, and also the primary setting,” they wrote.

The study illustrates a “framework for minimally invasive genomic characterization of metastatic cancer and subsequent integration with clinicopathologic data and patient outcomes,” the authors noted. “This approach has the potential to reveal clinically useful biomarkers while identifying unique genomic features of metastatic cancer and may advance our understanding of metastasis, drug resistance, and novel therapeutic targets.”

Dawson’s group wrote that with “the current lack of prognostic markers in metastatic TNBC, a reliable marker that can be obtained using a minimally invasive blood draw could have important implications.”

They also pointed out that it was important to note that the SCNA analysis was only performed on those patients (63.9% of the cohort) whose TFx was ≥10%. “High-confidence copy number calls could not be achieved for samples with a TFx < 10%, " they wrote, adding this would "limit the applicability of this approach in patients with early-stage disease."

But considering the challenges posed by the heterogeneity of TNBC, and the lack of targeted therapeutic options in treating the disease, the “era of comprehensive molecular characterization promises to pave the way forward,” Dawson’s group wrote.

The study was supported by the Gerstner Family Foundation, Susan G. Komen for the Cure, The Pink Agenda, Breast Cancer Research Foundation, the V Foundation for Cancer Research, and Dana-Farber/Harvard Cancer Center National Cancer Institute Specialized Programs of Research Excellence in Breast Cancer.

Stover disclosed no relevant relationships with industry. Co-authors disclosed multiple relevant relationships with industry.

Dawson and co-author disclosed support from Cancer Therapeutics CRC, the National Breast Cancer Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-12-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles